Modeling gastric intestinal metaplasia in 3D organoids using nitrosoguanidine.
Li Y, Chen J, Li T, Lin J, Zheng H, Johnson N, Yao X, Ding X.
J Mol Cell Biol. 2024 Dec 20;16(7):mjae030. doi: 10.1093/jmcb/mjae030.
Pathogenesis and potential reversibility of intestinal metaplasia - a milestone in gastric carcinogenesis.
Drnovsek J, Homan M, Zidar N, Smid LM.
Radiol Oncol. 2024 Apr 21;58(2):186-195. doi: 10.2478/raon-2024-0028. eCollection 2024 Jun 1.
Intestinal metaplasia, atrophic gastritis and stomach cancer: trends over time.
Sipponen P, Kimura K.
Eur J Gastroenterol Hepatol. 1994 Dec;6 Suppl 1:S79-83.
Intestinal metaplasia at the gastroesophageal junction: Barrett's, bacteria, and biomarkers.
Morales CP, Spechler SJ.
Am J Gastroenterol. 2003 Apr;98(4):759-62. doi: 10.1111/j.1572-0241.2003.07393.x.
Intestinal metaplasia of the stomach as a precancerous stage.
Sugimura T, Matsukura N, Sato S.
IARC Sci Publ. 1982;(39):515-30.
Is intestinal metaplasia of the stomach reversible?
Walker MM.
Gut. 2003 Jan;52(1):1-4. doi: 10.1136/gut.52.1.1.
Gastric intestinal metaplasia revisited: function and regulation of CDX2.
Barros R, Freund JN, David L, Almeida R.
Trends Mol Med. 2012 Sep;18(9):555-63. doi: 10.1016/j.molmed.2012.07.006. Epub 2012 Aug 4.
Intestinal metaplasia is not a strong risk factor for bladder cancer: study of 53 cases with long-term follow-up.
Corica FA, Husmann DA, Churchill BM, Young RH, Pacelli A, Lopez-Beltran A, Bostwick DG.
Urology. 1997 Sep;50(3):427-31. doi: 10.1016/S0090-4295(97)00294-X.
Gastric-and-intestinal mixed-type intestinal metaplasia: aberrant expression of transcription factors and stem cell intestinalization.
Tsukamoto T, Mizoshita T, Tatematsu M.
Gastric Cancer. 2006;9(3):156-66. doi: 10.1007/s10120-006-0375-6.
Columnar mucosa and intestinal metaplasia of the esophagus: fifty years of controversy.
DeMeester SR, DeMeester TR.
Ann Surg. 2000 Mar;231(3):303-21. doi: 10.1097/00000658-200003000-00003.
